This is the mechanism of action of 'THRIL' -- a newly discoverd TNF-alpha regulator. Credit: RANA
Sanford-Burnham Medical Research Institute scientists have discovered a new molecule that forms when certain white blood cells—macrophages—are stimulated in response to pathogens. The molecule, termed "THRIL," helps regulate the immune response and shows an association with Kawasaki disease. The findings suggest that THRIL may contribute to other inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.
The study, published online in Proceedings of the National Academy of Sciences, measured large intergenic noncoding RNA (lincRNA) produced when the immune system is activated. One lincRNA was found to bind heterogenous nuclear ribonucleoprotein L (hnRNPL), creating a new molecule that regulates genetic control of TNF-alpha—a potent cytokine that promotes inflammation. The authors named the molecule THRIL, after TNF-alpha and hnRNPL-related immunoregulatory lincRNA.
Noncoding RNAs as key regulators of immune response
Large noncoding RNA corresponds to the parts of the genome that do not code for protein.
"For some time we have known that noncoding regions of RNA play important roles in regulating the immune response to microbial pathogens," said Tariq Rana, Ph.D., senior author of the study and professor in the Sanford Children's Health Research Center and director of the RNA Biology Program at Sanford-Burnham. "When we realized that THRIL functioned to control the TNF-alpha gene, we wanted to see if it mirrors the progression in inflammatory diseases."
Collaborating with Jane Burns, M.D., professor of pediatrics at Rady Children's Hospital and UC San Diego, Rana's team measured THRIL levels in Kawasaki disease samples at different stages of the disease, and found that levels were at their lowest during the acute stage of the disease—when TNF-alpha levels are at their highest.
The findings suggest that THRIL could be a novel biomarker for immune activation and a potential target for inflammatory diseases.
Explore further: Target for new Rx class for inflammatory disorders discovered
Medical Xpress on facebook
Related Stories
Target for new Rx class for inflammatory disorders discovered
Oct 03, 2013
Research led by Charles Nichols, PhD, Associate Professor of Pharmacology at LSU Health Sciences Center New Orleans, describes a powerful new anti-inflammatory mechanism that could lead to the development of new oral medications ...
Researchers identify new target to treat psoriasis
Dec 05, 2013
Sanford-Burnham scientists have identified the B and T Lymphocyte Attenuator (BTLA) inhibitory receptor as a key factor in limiting inflammatory responses, particularly in the skin. The study, published online ...
New insights into the immune system of the gastrointestinal tract
Dec 09, 2013
Lymphotoxin is a cytokine, or intercellular messenger, and plays an important role in the immunological balance of the gastrointestinal tract. It regulates the immune system of the digestive tract, which is made up of immune ...
Immune response linked to key enzyme
Apr 12, 2013
(Medical Xpress)—A previously unknown function of a family of enzymes familiar to biologists may contribute to scientists' understanding of signaling molecules involved in the body's immune response and ...
Researchers probe the enigma of healing element that is also the enemy
Apr 03, 2013
The same factor in our immune system that is instrumental in enabling us to fight off severe and dangerous inflammatory ailments is also a player in doing the opposite at a later stage, causing the suppression of our immune ...
Recommended for you
Building a better malaria vaccine: Mixing the right cocktail
2 hours ago
A safe and effective malaria vaccine is high on the wish list of most people concerned with global health. Results published on December 26 in PLOS Pathogens suggest how a leading vaccine candidate could ...
Antioxidant drug knocks down multiple sclerosis-like disease in mice
4 hours ago
Researchers at Oregon Health & Science University have discovered that an antioxidant designed more than a dozen years ago to fight damage within human cells significantly helps symptoms in mice that have a multiple sclerosis-like ...
Gene therapy for human skin disease produces long-term benefits
7 hours ago
Stem cell-based gene therapy holds promise for the treatment of devastating genetic skin diseases, but the long-term clinical outcomes of this approach have been unclear. In a study online December 26th in the ISSCR's journal ...
Using maths, researchers seek to improve success in transplants
Dec 24, 2013
Given that 10.5% of patients who receive a transplant reject the new organ, researchers at the Center of Research and Advanced Studies of the National Polytechnic Institute (Cinvestav) are working in the ...
Study finds axon regeneration after Schwann cell graft to injured spinal cord
Dec 23, 2013
A study carried out at the University of Miami Miller School of Medicine for "The Miami Project to Cure Paralysis" has found that transplanting self-donated Schwann cells (SCs, the principal ensheathing cells of the nervous ...
Transitioning epithelial cells to mesenchymal cells enhances cardiac protectivity
Dec 23, 2013
Cell-based therapies have been shown to enhance cardiac regeneration, but autologous (patient self-donated) cells have produced only "modest results." In an effort to improve myocardial regeneration through cell transplantation, ...
User comments
© Medical Xpress 2011-2013, Science X network
This is the mechanism of action of 'THRIL' -- a newly discoverd TNF-alpha regulator. Credit: RANA
Sanford-Burnham Medical Research Institute scientists have discovered a new molecule that forms when certain white blood cells—macrophages—are stimulated in response to pathogens. The molecule, termed "THRIL," helps regulate the immune response and shows an association with Kawasaki disease. The findings suggest that THRIL may contribute to other inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.
The study, published online in Proceedings of the National Academy of Sciences, measured large intergenic noncoding RNA (lincRNA) produced when the immune system is activated. One lincRNA was found to bind heterogenous nuclear ribonucleoprotein L (hnRNPL), creating a new molecule that regulates genetic control of TNF-alpha—a potent cytokine that promotes inflammation. The authors named the molecule THRIL, after TNF-alpha and hnRNPL-related immunoregulatory lincRNA.
Noncoding RNAs as key regulators of immune response
Large noncoding RNA corresponds to the parts of the genome that do not code for protein.
"For some time we have known that noncoding regions of RNA play important roles in regulating the immune response to microbial pathogens," said Tariq Rana, Ph.D., senior author of the study and professor in the Sanford Children's Health Research Center and director of the RNA Biology Program at Sanford-Burnham. "When we realized that THRIL functioned to control the TNF-alpha gene, we wanted to see if it mirrors the progression in inflammatory diseases."
Collaborating with Jane Burns, M.D., professor of pediatrics at Rady Children's Hospital and UC San Diego, Rana's team measured THRIL levels in Kawasaki disease samples at different stages of the disease, and found that levels were at their lowest during the acute stage of the disease—when TNF-alpha levels are at their highest.
The findings suggest that THRIL could be a novel biomarker for immune activation and a potential target for inflammatory diseases.
Explore further: Target for new Rx class for inflammatory disorders discovered
Medical Xpress on facebook
Related Stories
Target for new Rx class for inflammatory disorders discovered
Oct 03, 2013
Research led by Charles Nichols, PhD, Associate Professor of Pharmacology at LSU Health Sciences Center New Orleans, describes a powerful new anti-inflammatory mechanism that could lead to the development of new oral medications ...
Researchers identify new target to treat psoriasis
Dec 05, 2013
Sanford-Burnham scientists have identified the B and T Lymphocyte Attenuator (BTLA) inhibitory receptor as a key factor in limiting inflammatory responses, particularly in the skin. The study, published online ...
New insights into the immune system of the gastrointestinal tract
Dec 09, 2013
Lymphotoxin is a cytokine, or intercellular messenger, and plays an important role in the immunological balance of the gastrointestinal tract. It regulates the immune system of the digestive tract, which is made up of immune ...
Immune response linked to key enzyme
Apr 12, 2013
(Medical Xpress)—A previously unknown function of a family of enzymes familiar to biologists may contribute to scientists' understanding of signaling molecules involved in the body's immune response and ...
Researchers probe the enigma of healing element that is also the enemy
Apr 03, 2013
The same factor in our immune system that is instrumental in enabling us to fight off severe and dangerous inflammatory ailments is also a player in doing the opposite at a later stage, causing the suppression of our immune ...
Recommended for you
Building a better malaria vaccine: Mixing the right cocktail
2 hours ago
A safe and effective malaria vaccine is high on the wish list of most people concerned with global health. Results published on December 26 in PLOS Pathogens suggest how a leading vaccine candidate could ...
Antioxidant drug knocks down multiple sclerosis-like disease in mice
4 hours ago
Researchers at Oregon Health & Science University have discovered that an antioxidant designed more than a dozen years ago to fight damage within human cells significantly helps symptoms in mice that have a multiple sclerosis-like ...
Gene therapy for human skin disease produces long-term benefits
7 hours ago
Stem cell-based gene therapy holds promise for the treatment of devastating genetic skin diseases, but the long-term clinical outcomes of this approach have been unclear. In a study online December 26th in the ISSCR's journal ...
Using maths, researchers seek to improve success in transplants
Dec 24, 2013
Given that 10.5% of patients who receive a transplant reject the new organ, researchers at the Center of Research and Advanced Studies of the National Polytechnic Institute (Cinvestav) are working in the ...
Study finds axon regeneration after Schwann cell graft to injured spinal cord
Dec 23, 2013
A study carried out at the University of Miami Miller School of Medicine for "The Miami Project to Cure Paralysis" has found that transplanting self-donated Schwann cells (SCs, the principal ensheathing cells of the nervous ...
Transitioning epithelial cells to mesenchymal cells enhances cardiac protectivity
Dec 23, 2013
Cell-based therapies have been shown to enhance cardiac regeneration, but autologous (patient self-donated) cells have produced only "modest results." In an effort to improve myocardial regeneration through cell transplantation, ...
User comments
© Medical Xpress 2011-2013, Science X network
0 comments:
Post a Comment